# Page 1
Grant of administrative approval for emergency purchase of medicines for Haemophilia and Thalassemia under Blood Cell.
The Government of Maharashtra
the Department of Public Health
Government Resolution Sanitary Number: PRASHAMA-0518/ PR No. 284/ Arogya-7 10th Floor, Gokuldas Tejpal Hospital Complex Building,
New Ministry, Mumbai- 400001.
The date: November 6, 2018.
Read: 1) Additional Mission Director, National Urban Health Mission, Mumbai vide letter No. Procurement of medicines on emergency basis/ Department of Hematology/ 18, dated 23rd May, 2018.
2) Department of Public Health, Decision dated 26/06/2018.
3) Commissioner, Director of Health Services and Mission Director, National Health Mission, Mumbai vide letter No. RAA/ State Blood Cell/ Government Resolution Amendment/ 39889/18 dated 07.08.2018.
4) Department of Public Health, Decision dated 31/08/2018.
5) Additional Mission Director, National Health Mission, Mumbai vide letter No. RAASO/ State Blood Cell/ Sanitization Card/ 58817/18 dated 21st September, 2018.
Government's decision:
Government Reference No. Hemophilia under the blood cell according to the decision of the Government of 2 and
Emergency purchase of Thalassemia drugs
The decision taken by the government vide reference no. 4 has been released
The Government Decision dated 31/08/2018 is hereby cancelled. Reference No. of 2.
Thalassemia and haemophilia drugs have been allowed to be purchased as per the government decision.
Administrative approval is being obtained. Similarly, reference No. The decision of the 2
The table below is being inserted instead of the table in paragraph 1. In the table
# Page 2
Government Resolution Purse No: PRASHAMA-0518/ PR No.284/ Arogya-7
All prices are inclusive of GST and other applicable taxes.
The drug has been given administrative approval.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| SR. No.                                                                       | Medicine Name              | Unit Rate Including all Taxes (Rs. ) | Total Qty. | Total In Rs. | Remark             |
| 1                                                                             | Factor VII / 1mg           | 41275.5 / mg                         | 703 mg     | 2,90,16,677/ | ESIC Rate Contract |
| 2                                                                             | Factor VIII Vial of 250 IU | 2025.45 / Vial                       | 8250 Vials | 1,67,09,963/ |
| 3                                                                             | Factor IX Vial of 600 IU   | 9012 / Vial                          | 2172 Vials | 1,95,74,064/ |
| 4                                                                             | FEIBA Vial of 500 IU       | 23415 / Vial                         | 1250 Vials | 2,92,68,750/ |
| 5                                                                             | Tab. Deferasirox - 250mg   | 11.8384 / Tablet                     | 247750     | 29,32,964/   | DHS Tender Rate    |
| 6                                                                             | Tab. Deferasirox- 500 mg   | 19.4656 / Tablet                     | 227750     | 44,33,290/   |
| 7                                                                             | Deferiprone (250 mg)       | 4.4 / Tablet                         | 17250      | 75,900/      |
| 8                                                                             | Tab. Deferiprone - 500 mg  | 7.7/Tablet                           | 38500      | 2,96,450/    |
| Total in Rs.:- Ten Crores Twenty Three Lakhs Eight Thousand Fifty Eight Only. | 10,23,08,058/              |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai.
The Office of Reference No. 5 As per the proposal submitted by the Government dated 26/06/2018
Subject to the terms and conditions of the Government decision, Rs. The drug is worth Rs 10.85 crore.
Procurement by Haffkine Biopharma, Mumbai in this regard pursuant to Administrative Sanction Fund
The purchase of the drug is approved by the government.
# Page 3